DOCS moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 46 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 83%.
The 10-day RSI Indicator for DOCS moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 20 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DOCS as a result. In 59 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for DOCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 30 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCS advanced for three days, in 210 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
DOCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 135 of 185 cases where DOCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. DOCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.326) is normal, around the industry mean (4.523). P/E Ratio (36.122) is within average values for comparable stocks, (12.601). Projected Growth (PEG Ratio) (0.590) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (7.776) is also within normal values, averaging (6.105).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
EXFY moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EXFY as a result. In 78 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for EXFY turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 33 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
The 10-day moving average for EXFY crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXFY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for EXFY entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXFY advanced for three days, in 170 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
EXFY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.389) is normal, around the industry mean (-1.939). P/E Ratio (-12.059) is within average values for comparable stocks, (9.673). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.843). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (1.573) is also within normal values, averaging (71.334).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. EXFY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
| DOCS | EXFY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 89% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 88% |
| Advances ODDS (%) | 24 days ago 75% | 9 days ago 74% |
| Declines ODDS (%) | 1 day ago 78% | 1 day ago 87% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 73% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DOCS’s FA Score shows that 0 FA rating(s) are green while EXFY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DOCS’s TA Score shows that 4 TA indicator(s) are bullish while EXFY’s TA Score has 4 bullish TA indicator(s).
DOCS (@Services to the Health Industry) experienced а -10.81% price change this week, while EXFY (@Packaged Software) price change was -15.59% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -11.07%. For the same industry, the average monthly price growth was -10.11%, and the average quarterly price growth was +4.62%.
The average weekly price growth across all stocks in the @Packaged Software industry was -10.16%. For the same industry, the average monthly price growth was -12.69%, and the average quarterly price growth was -7.50%.
DOCS is expected to report earnings on Feb 11, 2027.
EXFY is expected to report earnings on Feb 25, 2027.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Packaged Software (-10.16% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
A.I.dvisor indicates that over the last year, DOCS has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DOCS jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To DOCS | 1D Price Change % | ||
|---|---|---|---|---|
| DOCS | 100% | -3.46% | ||
| COIN - DOCS | 57% Loosely correlated | -1.48% | ||
| PUBM - DOCS | 54% Loosely correlated | -4.21% | ||
| CLSK - DOCS | 53% Loosely correlated | -5.96% | ||
| COMP - DOCS | 53% Loosely correlated | -1.58% | ||
| RIOT - DOCS | 49% Loosely correlated | -2.80% | ||
More | ||||
A.I.dvisor indicates that over the last year, EXFY has been loosely correlated with CLSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EXFY jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To EXFY | 1D Price Change % | ||
|---|---|---|---|---|
| EXFY | 100% | -2.48% | ||
| CLSK - EXFY | 53% Loosely correlated | -5.96% | ||
| COIN - EXFY | 47% Loosely correlated | -1.48% | ||
| RIOT - EXFY | 46% Loosely correlated | -2.80% | ||
| DOCS - EXFY | 44% Loosely correlated | -3.46% | ||
| HOOD - EXFY | 44% Loosely correlated | -0.75% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NAZ | 10.08 | -0.03 | -0.30% |
| Nuveen Arizona Quality Municipal Income Fund | |||
| RSSB | 28.06 | -0.49 | -1.72% |
| Return Stacked Global Stocks & Bonds ETF (RSSB) | |||
| REMC | 22.34 | -0.40 | -1.76% |
| Columbia Research Enhanced Mid Cap ETF (REMC) | |||
| PSCC | 36.27 | -0.72 | -1.94% |
| Invesco S&P SmallCap Consumer Staples ETF (PSCC) | |||
| AAXJ | 98.01 | -2.01 | -2.01% |
| iShares MSCI All Country Asia ex Japan ETF (AAXJ) | |||